Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.
Nasal NK/T cell lymphomas (NKTCL) are a subset of aggressive Epstein-Barr virus (EBV)-associated non-Hodgkin's lymphomas. The role of EBV in pathogenesis of NKTCL is not clear. Intriguingly, EBV encodes more than 40 microRNAs (miRNA) that are differentially expressed and largely conserved in ly...
Main Authors: | Rajesh Ramakrishnan, Hart Donahue, David Garcia, Jie Tan, Norio Shimizu, Andrew P Rice, Paul D Ling |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3213120?pdf=render |
Similar Items
-
The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo.
by: Jin Qiu, et al.
Published: (2015-01-01) -
Modulation of LMP2A Expression by a Newly Identified Epstein-Barr Virus-Encoded MicroRNA miR-BART22
by: Raymond Wai-Ming Lung, et al.
Published: (2009-11-01) -
Transcriptome Changes Induced by Epstein-Barr Virus LMP1 and LMP2A in Transgenic Lymphocytes and Lymphoma
by: Kathy H. Y. Shair, et al.
Published: (2012-11-01) -
CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals.
by: Mayumi Yoshimori, et al.
Published: (2014-01-01) -
LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL)
by: Mao Yuan, et al.
Published: (2012-12-01)